Some results from these studies showed that increased α-synuclein in neuron-derived EVs from serum can predict and differentiate PD from atypical parkinsonian syndromes, and that the evaluation of α-synuclein and aggregated tau in neuron-derived EVs enables us to distinguish between PD and atypical parkinsonian syndrome [81]. This evidence concerns the gene MAPT and Parkinson disease.